Yoni Freedhoff

Recent research suggests that patients prescribed GLP-1s don’t fill their prescriptions or stop taking them. Yoni Freedhoff, MD, discusses the obstacles to patient adherence.

Recent reports that the decrease in obesity rates is due to increased prescribing of antiobesity medications are unfounded. Yoni Freedhoff, MD, explains why it’s just not possible.

There’s no debate that diet and exercise aren’t more effective for people with obesity than antiobesity medications, contends Yoni Freedhoff, MD.

Advertising sugary cereals and salty snacks to kids is rampant on social media. Do bans on such marketing create a decrease in the demand for these processed foods?

Two prominent medical associations recommend treating people with obesity like actual people. Yoni Freedhoff, MD, explains why this is another form of bias.

Nestlé recently announced they would sell food targeted for customers on anti-obesity medications. Yoni Freedhoff, MD, explains why this move should be celebrated.

New research touted that kimchi consumption can stave off weight gain. Yoni Freedhoff, MD, points out the flaws in the research.

New draft recommendations focus on lecturing children with obesity about diet while ignoring medications or surgery. Dr Yoni Freedhoff says this is another form of weight bias.

Paying people with obesity to lose weight worked in a recent study, but Dr Yoni Freedhoff contends that it’s not a long-term solution.

A recent initiative asks that prepared food labels include how much exercise it will take to burn off. Dr Yoni Freedhoff explains why this won’t work.

Dr Yoni Freedhoff explains that studies promoting short-term weight-loss programs don’t really have any value as the programs are not sustainable.